文献速递乳腺US

基于临床病理、常规超声与超声造影成像特征预测乳腺浸润性导管癌患者无复发生存

Prediction of recurrence-free survival in patients with invasive ductal carcinoma of the breast on the basis of clinicopathological, conventional ultrasound and contrast-enhanced ultrasound imaging characteristics.
PubMed 文献 · Clin Radiol · 2026-01-20

本研究回顾性纳入2016至2020年本院377例乳腺浸润性导管癌患者,整合临床病理、常规超声及超声造影特征构建列线图预测1、3、5年无复发生存。腋窝淋巴结负荷、雌激素受体状态、彩色多普勒血流成像血流、超声造影最大长径及灌注缺损为独立危险因素,模型在训练组与验证组AUC分别为0.876、0.823、0.753与0.731、0.763、0.714,校准曲线一致性良好。

要点

  • 腋窝淋巴结负荷、雌激素受体状态、彩色多普勒血流、超声造影最大长径及灌注缺损为无复发生存独立危险因素。
  • 列线图预测训练组1、3、5年无复发生存AUC为0.876、0.823、0.753,验证组为0.731、0.763、0.714。
  • 该列线图作为补充预后工具,可提供个体化风险分层以辅助临床决策。

核心结论

  • 整合临床病理与超声特征的列线图可作为乳腺浸润性导管癌患者的补充预后工具,提供个体化风险分层以支持临床决策,可能减少低危患者干预并优先监测高危病例,同时补充传统分期系统。

研究设计与样本

  • 回顾性分析2016至2020年本院经病理确诊的乳腺浸润性导管癌患者,共纳入377例,分为训练组226例与验证组151例;基于临床病理及超声数据行Cox回归分析筛选独立因素,构建并验证列线图预测1、3、5年无复发生存,以AUC、校准曲线及决策曲线分析评估模型性能、校准与临床适用性。

关键影像表现/征象

  • 彩色多普勒血流成像显示的血流为无复发生存的独立危险因素。
  • 超声造影上测得的最大长径为无复发生存的独立危险因素。
  • 超声造影上见灌注缺损为无复发生存的独立危险因素。

诊断标准与关键数值

  • 列线图预测训练组1年无复发生存AUC为0.876。
  • 列线图预测训练组3年无复发生存AUC为0.823。
  • 列线图预测训练组5年无复发生存AUC为0.753。
  • 列线图预测验证组1年无复发生存AUC为0.731。
  • 列线图预测验证组3年无复发生存AUC为0.763,5年AUC为0.714。

临床应用与阅片要点

  • 阅片时可关注超声造影最大长径及灌注缺损,并结合彩色多普勒血流、腋窝淋巴结负荷与雌激素受体状态综合评估无复发生存风险。
  • 列线图预测的1、3、5年无复发生存概率与校准曲线显示预测与实际值一致性良好,可用于个体化风险分层。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: This study aimed to incorporate clinicopathological, conventional ultrasound (US) and contrast-enhanced US (CEUS) imaging features to establish a predictive model for evaluating recurrence-free survival (RFS) in patients with invasive ductal carcinoma (IDC) of the breast.

MATERIALS AND METHODS: Patients confirmed with IDC in our hospital between 2016 and 2020 were retrospectively analysed. We performed Cox regression analyses based on the clinicopathological and USdata to identify independent factors. A nomogram model was constructed and verified to predict the 1-, 3-, and 5-year RFS. Nomogram performance, calibration, and clinical applicability were evaluated with the area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis.

RESULTS: A total of 377 patients were included and divided into training group (n=226) and validation group (n=151). Axillary lymph node burden, oestrogen receptor status, colour Doppler flow imaging blood flow, maximum length diameter on CEUS, and perfusion defects were independent risk factors for poor RFS. The AUC values of nomogram model were 0.876, 0.823, and 0.753 in the training group and 0.731, 0.763, and 0.714 in the validation group. The calibration curves exhibited good concordance between the predicted survival probabilities and the actual values.

CONCLUSION: The nomogram, which integrates clinicopathological and US features, serves as a supplementary prognostic tool for IDC patients. It offers individualised risk stratification to support clinical decision-making, potentially minimising interventions for low-risk patients and prioritising monitoring for high-risk cases, while complementing traditional staging systems.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Kuang Y, Zheng Y, Li G, et al. Prediction of recurrence-free survival in patients with invasive ductal carcinoma of the breast on the basis of clinicopathological, conventional ultrasound and contrast-enhanced ultrasound imaging characteristics. Clin Radiol. 2026. PMID: 41865649. doi:10.1016/j.crad.2026.107256

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。